Radiotherapy of hepatic metastases;Strahlentherapie von Lebermetastasen

Chirurg

Volumn 81, Issue 6, 2010, Pages 526-532

  Combs, S E ^a   Herfarth, K K ^a   Habermehl, D ^a   Debus, J ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Hepatic metastases; Local control; Precision radiotherapy; Side effects; Stereotactic radiotherapy

Indexed keywords

ARTICLE; COLORECTAL TUMOR; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE PROCESSING; LIVER TUMOR; METASTASIS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT CARE; RADIATION DOSE; RADIOSURGERY; THREE DIMENSIONAL IMAGING;

COLORECTAL NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; PATIENT CARE TEAM; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954082001     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-010-1889-3     Document Type: Article

References (32)

1. Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21: 109-122.
2. Austin-Seymour MM, Chen GT, Castro JR et al (1986) Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys 12: 31-35.
3. Olsen CC, Welsh J, Kavanagh BD et al (2009) Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 73: 1414-1424.
4. Hoegler D (1997) Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer 21: 129-183.
5. Sherman DM, Weichselbaum R, Order SE et al (1978) Palliation of hepatic metastasis. Cancer 41: 2013-2017.
6. Borgelt BB, Gelber R, Brady LW et al (1981) The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 7: 587-591.
7. Lawrence TS, Ten Haken RK, Kessler ML et al (1992) The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23: 781-788.
8. Combs SE, Schulz-Ertner D, Thilmann C et al (2004) Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery. Strahlenther Onkol 180: 590-596.
9. Combs SE, Welzel T, Schulz-Ertner D et al (2010) Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 76: 193-200.
10. Blomgren H, Lax I, Naslund I, Svanstrom R (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34: 861-870.
11. Herfarth KK, Debus J, Lohr F et al (2000) Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 46: 329-335.
12. Lohr F, Debus J, Frank C et al (1999) Noninvasive patient fixation for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 45: 521-527.
13. Keall PJ, Joshi S, Vedam SS et al (2005) Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys 32: 942-951.
14. Guckenberger M, Krieger T, Richter A et al (2009) Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 91: 288-295.
15. Rietzel E, Rosenthal SJ, Gierga DP et al (2004) Moving targets: detection and tracking of internal organ motion for treatment planning and patient set-up. Radiother Oncol 73(Suppl 2): 68-72.
16. Herfarth KK, Debus J, Lohr F et al (2001) Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19: 164-170.
17. Herfarth KK, Hof H, Bahner ML et al (2003) Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57: 444-451.
18. Herfarth KK, Debus J (2005) Stereotactic radiation therapy for liver metastases. Chirurg 76: 564-569.
19. Rusthoven KE, Kavanagh BD, Cardenes H et al (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27: 1572-1578.
20. McCammon R, Schefter TE, Gaspar LE et al (2009) Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 73: 112-118.
21. Milano MT, Katz AW, Okunieff P (2009) Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ. Am J Clin Oncol.
22. Milano MT, Katz AW, Schell MC et al (2008) Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 72: 1516-1522.
23. Mendez RA, Zinkstok RT, Wunderink W et al (2009) Stereotactic body radiation therapy for liver tumors: impact of daily setup corrections and day-to-day anatomic variations on dose in target and organs at risk. Int J Radiat Oncol Biol Phys 75: 1201-1208.
24. Mendez RA, Wunderink W, Hussain SM et al (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol 45: 831-837.
25. Wulf J, Hadinger U, Oppitz U et al (2001) Stereotactic radiotherapy of targets in the lung and liver. Strahlenther. Onko177: 645-655.
26. Wada H, Takai Y, Nemoto K, Yamada S (2004) Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 58: 1114-1120.
27. Schefter TE, Kavanagh BD, Timmerman RD et al(2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62: 1371-1378.
28. Hoyer M, Roed H, Traberg HA et al (2006) Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45: 823-830.
29. Kavanagh BD, Schefter TE, Cardenes HR et al (2006) Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45: 848-855.
30. Wurm RE, Gum F, Erbel S, Schlenger L, Scheffler D, Agaoglu D et al. Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol 2006; 45: 881-889.
31. Katz AW, Carey-Sampson M, Muhs AG et al (2007) Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 67: 793-798.
32. Lee MT, Kim JJ, Dinniwell R et al (2009) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27: 1585-1591.